financetom
Market
financetom
/
Market
/
JGB yields mixed as investors eye BOJ policy meeting, US GDP
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
JGB yields mixed as investors eye BOJ policy meeting, US GDP
Apr 24, 2024 8:36 PM

TOKYO, April 25 (Reuters) - Japanese government bond

(JGB) yields struggled for a clear direction on Thursday, as

investors awaited more clues on the interest rate paths of both

the Federal Reserve and the Bank of Japan (BOJ) ahead of key

U.S. economic data and the BOJ's policy decision.

The 10-year JGB yield rose 0.5 basis point

(bp) to 0.890%, sitting at its highest since Nov. 13, as the BOJ

began its two-day policy meeting.

Although the BOJ is expected to stand pat at its April

meeting, it is likely to project that inflation will stay around

its 2% target for the next three years in new forecasts.

The yen's slide to fresh 34-year lows, however, may force

BOJ Governor Kazuo Ueda to walk a delicate line in guiding

monetary policy.

The Japanese currency hit a new 34-year low of 155.45

against the U.S. dollar on Thursday, sparking fresh concerns as

to whether Tokyo will intervene.

With the two-year JGB yield, which is highly sensitive to

the BOJ's policy, already up near 0.3%, the market has probably

already priced in another rate hike in July, Makoto Suzuki, a

senior bond strategist at Okasan Securities said.

"But if there is any change in the U.S. economy in those

three months, that could change, so essentially we are just

watching the U.S. economy," he added.

The two-year JGB yield fell 0.5 bp to 0.295%

on Thursday, after touching 0.3%, its highest level since July

2009, earlier this week.

Attention will also be on U.S. first quarter gross domestic

product data, due later on Thursday, and personal consumption

expenditures for March due on Friday.

Elsewhere on the short-end, the five-year yield

ticked up 0.5 bp to 0.495%.

The 20-year JGB yield was 0.5 bp lower at

1.650%, while the 30-year JGB yield fell 1.5

bps to 1.935%.

The 40-year JGB yield slid 2 bps to 2.275%.

(Reporting by Brigid Riley; Editing by Mrigank Dhaniwala)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Sector Update: Tech
Sector Update: Tech
Jun 11, 2024
08:49 AM EDT, 06/11/2024 (MT Newswires) -- Technology stocks were mixed premarket Tuesday, with the Technology Select Sector SPDR Fund (XLK) down 0.2% and the SPDR S&P Semiconductor ETF (XSD) 1.4% higher. Yext ( YEXT ) shares were down more than 15% after the company overnight reported lower fiscal Q1 non-GAAP earnings and revenue. ...
Dell, Applied Materials And 2 Other Stocks Insiders Are Selling
Dell, Applied Materials And 2 Other Stocks Insiders Are Selling
Jun 11, 2024
The Nasdaq 100 closed higher by around 0.4% on Monday. Investors, meanwhile, focused on some notable insider trades. When insiders sell shares, it could be a preplanned sale, or could indicate their concern in the company's prospects or that they view the stock as being overpriced. Insider sales should not be taken as the only indicator for making an investment...
US STOCKS-Futures ease on rate-cut jitters ahead of inflation data, Fed meet
US STOCKS-Futures ease on rate-cut jitters ahead of inflation data, Fed meet
Jun 11, 2024
(For a Reuters live blog on U.S., UK and European stock markets, click or type LIVE/ in a news window.) * Eli Lilly ( LLY ) up as Alzheimer's drug gets US FDA panel backing * Crypto stocks fall as bitcoin hits one-week low * GM approves $6 billion share buyback plan * Futures lower: Dow 0.31%, S&P 0.22%, Nasdaq...
Sector Update: Health Care
Sector Update: Health Care
Jun 11, 2024
08:52 AM EDT, 06/11/2024 (MT Newswires) -- Health care stocks were leaning lower premarket Tuesday, with the Health Care Select Sector SPDR Fund (XLV) inactive and the iShares Biotechnology ETF (IBB) down 0.4%. Viridian Therapeutics ( VRDN ) stock was up over 6% after the company said it would begin two late-stage clinical trials to evaluate VRDN-003 in patients with...
Copyright 2023-2025 - www.financetom.com All Rights Reserved